GSK In Developing Countries: The Unethical GSK (Hepatitis E) Nepalese Army Trials

GSK : Licence To (K) ill (Documenting GSK And Seroxat)

GSK  has sometimes behaved extremely unethically in developing countries, therefore everything the Yemeni whistle-blower has told me about GSK’s practices in Yemen really comes as no surprise to me..

 
‡
DoH §17: Investigations were not ceased after the
risks were found to outweigh the potential benefits.

Unethical aspects:

In 1998, GSK and the Walter Reed Institute, which conducts medical research for the US army, started cooperating to develop a Hepatitis E vaccine. Hepatitis E is a comon disease in poor countries and there have been outbreaks in countries where US troops are deployed. Preparations for phase II trials were made in February 2000. Before launching the trials, GSK had already decided the vaccine would not be commercially developed for a travellers’ market, while Walter Reed decided it would be unsuitable for US soldiers.
Still, GSK and Walter Reed went ahead with phase II trials and wanted to test…

View original post 2,079 more words

Advertisements

About IMVAlliance.org

An international network of military veterans, families and friends affected by the health impacts of the neurotoxic antimalarial drug, mefloquine.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s